Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol

References

• Hoffman BB. (2001). Catecholamines, sympatomimetics drug and adrenergic receptor antagonists. In: Hardman JG, Limbid LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York, NY: McGraw Hill, 235–8.
   Google Scholar
• Brown HC, Carruthers MD, Johnston GD. (1976). Clinical pharmacologic observations on atenolol, a β-adrenoreceptor blocker. Clin Pharmacol Ther, 20:524–34.
   PubMed Web of Science ®Google Scholar
• Sastry SV, Reddy IK, Kahn MA. (1997). Atenolol gastrointestinal therapeutic system: Optimization of formulation variables using response surface methodology. J Control Release, 45:121–30.
   Web of Science ®Google Scholar
• Cho CW, Shin SC. (2004). Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Int J Pharm, 287:67–71.
   PubMed Web of Science ®Google Scholar
• Hao J, Heng PWS. (2003). Buccal delivery systems. Drug Del Ind Pharm, 29:821–32.
   PubMed Web of Science ®Google Scholar
• Sudhakar Y, Koutsu K, Bandyopadhyay AK. (2006). Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Control Release, 114:15–40.
   PubMed Web of Science ®Google Scholar
• Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Del Rev, 57:1666–91.
   PubMed Web of Science ®Google Scholar
• Davis ME, Brewster ME. (2004). Cyclodextrin based Pharmaceutics: Past, Present and future. Nat Rev Drug Discovery, 3:1023–35.
   PubMed Web of Science ®Google Scholar
• Marttin E, Verhoef JC, Spies F, van der Meulen J, Nagelkerke JF, Koerten HK, (1999). The effect of methylated β-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: Electron microscopic and confocal laser scanning microscopic visualization studies. J Control Release, 57:205–13.
   PubMed Web of Science ®Google Scholar
• Masson M, Loftsson T, Masson G, Stefansson E. (1999). Cyclodextrins as permeation enhancers: Some theoretical evaluation and in vivo testing. J Control Release, 59:107–18.
   PubMed Web of Science ®Google Scholar
• Merkus FWHM, Verhoef JC, Marttin E, Romejin SG, van der Kuy PHM, Hermens WAJJ, (1999). Cyclodextrins in nasal drug delivery. Adv Drug Del Rev, 36:41–57.
   PubMed Web of Science ®Google Scholar
• Bouldmedarat L, Bochot A, Lesieur S, Fattal E. (2005). Evaluation of buccal methyl-β-cyclodextrin toxicity on human oral epithelial cell culture model. J Pharm Sci, 94:1300–9.
   PubMed Web of Science ®Google Scholar
• Verma N, Wahi AK, Verma A, Chattopadhayay P. (2007). Evaluation of a mucoadhesive buccal patch for delivery of atenolol. In vitro screening of bioadhesion. JPAM, 1:115–8.
   Google Scholar
• Satishbabu B, Srinivasan B. (2008). Preparation and evaluation of buccoadhesive films of atenolol. Ind J Pharm Sci, 70:175–9.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors K. (1965). Phase solubility techniques. Adv Anal Chem Instrum, 7:117–212.
   Google Scholar
• Loftsson T, Masson M, Sigurjonsdottir JF. (1999). Method to enhance the complexation efficiency of cyclodextrin. STP Pharma Sci, 9:237–42.
   Google Scholar
• Mura P, Zerrouk N, Faucci MT, Maestrelli F, Chemtob C. (2002). Comparative study of ibuproxam complexation with amorphous β-cyclodextrin derivates in solution and in solid state. Eur J Pharm Biopharm, 54:181–91.
   PubMed Web of Science ®Google Scholar
• Brown ME, Glass BD, Worthington MS. (2002). Binary systems of nifedipine and various cyclodextrins in the solid state: Thermal, FTIR XRD studies. J Therm Anal Calorim, 68:631–46.
   Web of Science ®Google Scholar
• Morita R, Honda R, Takashashi Y. (2000). Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design of SVRS and its release controlling factor. J Control Release, 63:297–304.
   PubMed Web of Science ®Google Scholar
• Kavanagh N, Corrigan OI. (2004). Swelling and erosion properties of hydroxypropyl methylcellulose (Hypromelose) matrices—influence of agitation rate and dissolution medium composition. Int J Pharm, 279:141–52.
   PubMed Web of Science ®Google Scholar
• Jacques Y, Bruni P. (1997). An investigation of the physical behaviour of moisture activated hydrogels upon contact with biological and nonbiological substrates. Pharm Acta Helv, 72:225–32.
   PubMedGoogle Scholar
• Soppimath KS, Kulkarni AR, Aminabhavi TM. (2001). Chemically modified polyacrylamide-g-guar gum-based crosslinked anionic microgels as pH-sensitive drug delivery systems: Preparation and characterization. J Control Release, 75:331–45.
   PubMed Web of Science ®Google Scholar
• Tobyn MA, Johnson JR, Dettmar PW. (1997). Factors affecting in vitro gastric mucoadhesion. IV. Influence of tablet excipients, surfactants and salts on the observed mucoadhesion of polymers. Eur J Pharm Biopharm, 43:65–71.
   Web of Science ®Google Scholar
• Loftsson T, Masson M. (2004). The effect of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs. J Drug Del Sci Tech, 14:35–43.
   Web of Science ®Google Scholar
• Azarmi S, Roa W, Löbenberg R. (2007). Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm, 328:12–21.
   PubMed Web of Science ®Google Scholar
• Han RY, Fang JY, Sung KC, Hu OYP. (1999). Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: Effect of formulation variables on drug release and mucoadhesive properties. Int J Pharm, 177:201–9.
   PubMed Web of Science ®Google Scholar
• Douroumis D, Fahr A. (2007). Stabile carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci, 30:367–74.
   PubMed Web of Science ®Google Scholar
• Khougaz K, Clas SD. (2000). Crystallization inhibition in solid dispersions of MK-0591 and polyvinylpyrrolidone polymers. J Pharm Sci, 89:1325–34.
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: Influence of polymers. Int J Pharm, 212:213–21.
   PubMed Web of Science ®Google Scholar
• Bibby DC, Davies NM, Tucker IG. (2000). Mechanism by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm, 197:1–11.
   PubMed Web of Science ®Google Scholar